These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 6247966)
1. Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria. Borobio MV; Aznar J; Jimenez R; Garcia F; Perea EJ Antimicrob Agents Chemother; 1980 Feb; 17(2):129-31. PubMed ID: 6247966 [TBL] [Abstract][Full Text] [Related]
2. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli. Hall WH; Opfer BJ; Gerding DN Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970 [TBL] [Abstract][Full Text] [Related]
3. Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria. Jorgensen JH; Crawford SA; Alexander GA Antimicrob Agents Chemother; 1980 May; 17(5):901-4. PubMed ID: 6249198 [TBL] [Abstract][Full Text] [Related]
4. Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli. Lang SD; Edwards DJ; Durack DT Antimicrob Agents Chemother; 1980 Mar; 17(3):488-93. PubMed ID: 6252831 [TBL] [Abstract][Full Text] [Related]
5. Susceptibility of anaerobic bacteria to cefoperazone and other beta-lactam antibiotics. Jacobus NV; Tally FP; Barza M; Gorbach SL Clin Ther; 1980; 3(Spec Issue):34-8. PubMed ID: 6446396 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides spp. Nasu M; Maskell JP; Williams RJ; Williams JD Antimicrob Agents Chemother; 1981 Oct; 20(4):433-6. PubMed ID: 6282191 [TBL] [Abstract][Full Text] [Related]
7. In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains. Baker CN; Thornsberry C; Jones RN Antimicrob Agents Chemother; 1980 Apr; 17(4):757-61. PubMed ID: 6249195 [TBL] [Abstract][Full Text] [Related]
8. LY127935, a novel oxa-beta-lactam: an in vitro comparison with other beta-lactam antibiotics. Wise R; Andrews JM; Bedford KA Antimicrob Agents Chemother; 1979 Sep; 16(3):341-5. PubMed ID: 507788 [TBL] [Abstract][Full Text] [Related]
9. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins]. Baumgärtner M; Dickgiesser N; Müller S; Wundt W Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361 [TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis. Thabaut A; Durosoir JL; Saliou P Chemotherapy; 1981; 27 Suppl 1():19-24. PubMed ID: 6265159 [TBL] [Abstract][Full Text] [Related]
11. Effect of inoculum size and beta-lactamase production on in vitro activity of new cephalosporins against Haemophilus species. Bulger RR; Washington JA Antimicrob Agents Chemother; 1980 Mar; 17(3):393-6. PubMed ID: 6448575 [TBL] [Abstract][Full Text] [Related]
12. N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics. Hanslo D; King A; Shannon K; Warren C; Phillips I J Antimicrob Chemother; 1981 Jun; 7(6):607-17. PubMed ID: 6265426 [No Abstract] [Full Text] [Related]
13. Comparative in vitro activity of first, second and third generation cephalosporins. Forsgren A Acta Pathol Microbiol Scand B; 1981 Aug; 89(4):221-5. PubMed ID: 6274143 [TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials. Jones RN; Wilson HW Diagn Microbiol Infect Dis; 1983 Mar; 1(1):71-83. PubMed ID: 6323095 [TBL] [Abstract][Full Text] [Related]
15. In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance. Brown JE; Del Bene VE; Collins CD Antimicrob Agents Chemother; 1981 Feb; 19(2):248-52. PubMed ID: 6214986 [TBL] [Abstract][Full Text] [Related]
16. In vitro activities of cefotaxime and moxalactam (LY127935) against Haemophilus influenzae. Jorgensen JH; Crawford SA; Alexander GA Antimicrob Agents Chemother; 1980 Mar; 17(3):516-7. PubMed ID: 6252832 [TBL] [Abstract][Full Text] [Related]
17. Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters. Verbist L Arzneimittelforschung; 1981; 31(6):982-6. PubMed ID: 6266430 [TBL] [Abstract][Full Text] [Related]
18. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains]. Mascellino MT; Prignano G; Iegri F; Lorenzi A Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234 [TBL] [Abstract][Full Text] [Related]
19. In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria. DeMaria A; Alvarez S; Klein JO; McCabe WR Infection; 1980; 8 Suppl 3():S 261-7. PubMed ID: 6447671 [TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli. Kurtz TO; Winston DJ; Hindler JA; Young LS; Hewitt WL; Martin WJ Antimicrob Agents Chemother; 1980 Oct; 18(4):645-8. PubMed ID: 6255864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]